Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
This invention relates to (+)-2-[1-(2,6-dichlorophenoxy)-ethyl]-1,3-diazacyclopent-2-ene and to pharmaceutically acceptable acid addition salts thereof and the method for the treatment of human beings suffering from nervous disarrangements, in particular migraine, using these compounds.
patent: 3966757 (1976-06-01), Baganz et al.
patent: 4025539 (1977-05-01), Baganz et al.
A. Nattermann & Cie GmbH
Friedman Stanley J.
(+)-2-[1-(2,6-Dichlorophenoxy)-ethyl]-1,3-diazacyclopent-2-ene a does not yet have a rating. At this time, there are no reviews or comments for this patent.If you have personal experience with (+)-2-[1-(2,6-Dichlorophenoxy)-ethyl]-1,3-diazacyclopent-2-ene a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (+)-2-[1-(2,6-Dichlorophenoxy)-ethyl]-1,3-diazacyclopent-2-ene a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-95365